Keytruda, the recently US approved drug shows early promise for some patients with advanced lung cancer though it is approved for advanced melanoma. The drug boosts the cancer-fighting potential and the body's immune system. Keytruda (pembrolizumab) belongs to a new group of drugs that block a pathway called PD-1, which then frees up the immune system to attack cancer cells approved another PD-1 drug nivolumab (Opdivo) for treating some cases of advanced lung ...
via Medindia Health News
More READ
No comments:
Post a Comment